These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 1993116)

  • 1. Hypersensitivity of delayed type in hypertensive patients.
    Olsen F
    APMIS; 1991 Jan; 99(1):65-8. PubMed ID: 1993116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Further evidence of the development of delayed-type autoimmunity against arterial vessel-wall antigens following acute hypertensive damage to arterial vessels in rats.
    Drivsholm L; Laybourn C; Olsen F
    Acta Pathol Microbiol Immunol Scand C; 1985 Jun; 93(3):105-10. PubMed ID: 3898720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delayed hypersensitivity and borderline essential hypertension.
    Olsen F; Rasmussen S
    Acta Pathol Microbiol Scand C; 1977 Jun; 85(3):196-8. PubMed ID: 878880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Duration of delayed-type autoimmunity against arterial vessel-wall antigens following acute hypertensive damage to arterial vessels in rats.
    Laybourn C; Drivsholm L; Olsen F
    Acta Pathol Microbiol Immunol Scand C; 1986 Jun; 94(3):127-30. PubMed ID: 3751586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delayed hypersensitivity and essential hypertension. Delayed hypersensitivity against arterial wall components as a pathogenetic factor in essential hypertension.
    Olsen F
    Acta Pathol Microbiol Scand B Microbiol Immunol; 1974 Jun; 82(3):448-50. PubMed ID: 4152830
    [No Abstract]   [Full Text] [Related]  

  • 6. Delayed hypersensitivity directed against arterial antigens in the hypertensive disease in man.
    Olsen F; Loft B
    Acta Pathol Microbiol Scand A; 1973 Jul; 81(4):498-500. PubMed ID: 4779701
    [No Abstract]   [Full Text] [Related]  

  • 7. Evidence of the development of delayed-type autoimmunity against arterial vessel-wall antigens following acute hypertensive damage to arterial vessels in rats.
    Olsen F; Laybourn C; Drivsholm L
    Acta Med Scand Suppl; 1985; 693():133-7. PubMed ID: 3857839
    [No Abstract]   [Full Text] [Related]  

  • 8. [Experimental studies on tuberculin hypersensitivity--immunological significance of leucocyte migration inhibitory factor (LIF) and macrophage migration inhibitory factor (MIF) (author's transl)].
    Matsui Y; Oshima S
    Kekkaku; 1979 Jun; 54(6):331-44. PubMed ID: 388018
    [No Abstract]   [Full Text] [Related]  

  • 9. Applicability of the leukocyte migration inhibition test in the clinical practice.
    Stanciu L; Dumitrescu D; Radu D
    Med Interne; 1990; 28(4):295-303. PubMed ID: 2100874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunopathogenic mechanisms in hypertension.
    Lefkos N; Boura P; Boudonas G; Zacharioudaki E; Efthimiadis A; Tsougas M; Epivatianos P
    Am J Hypertens; 1995 Nov; 8(11):1141-5. PubMed ID: 8554739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leucocyte migration inhibition in diphtheria toxoid hypersensitivity.
    Saxby MF; Salaman MR; Sargent IL
    Allergy; 1987 Aug; 42(6):473-6. PubMed ID: 3310718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delayed hypersensitivity and high blood pressure in man.
    Olsen F; Loft B
    Acta Pathol Microbiol Scand A; 1973 Mar; 81(2):145-7. PubMed ID: 4694013
    [No Abstract]   [Full Text] [Related]  

  • 13. Modulation of human T cell production of migration inhibitory lymphokines by cytokines derived from human leukocyte dialysates.
    Gottlieb AA; Farmer JL; Matzura CT; Hester RB; Rosenberg JS
    J Immunol; 1984 Jan; 132(1):256-60. PubMed ID: 6361122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Peripheral leukocyte migration inhibition test as an indication of specific reactivity of lymphocytes in delayed hypersensitivity].
    Halama G
    Pol Tyg Lek; 1976 Sep; 31(38):1655-8. PubMed ID: 62352
    [No Abstract]   [Full Text] [Related]  

  • 15. The in vivo effect of thymic factor (thymostimulin) administration in Hodgkin's disease patients. Correlation of skin reactivity and leukocyte migration-inhibition factor in the sera of anergic subjects.
    Velardi A; Rambotti P; Cernetti C; Spinozzi F; Bertotto A; Martelli MF
    Thymus; 1983 Sep; 5(5-6):429-32. PubMed ID: 6362105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Phenomenon of blood leukocyte migration inhibition in guinea pigs with delayed-type hypersensitivity to a foreign tissue antigen].
    Artemova AG
    Biull Eksp Biol Med; 1973 Oct; 75(10):67-71. PubMed ID: 4780161
    [No Abstract]   [Full Text] [Related]  

  • 17. [Macrophage migration inhibition test (MIT), leukocyte migration inhibition test (LMT)].
    Shimizu Y; Nakayama Y; Hirano K
    Nihon Rinsho; 2005 Jul; 63 Suppl 7():784-7. PubMed ID: 16111394
    [No Abstract]   [Full Text] [Related]  

  • 18. Agarose microdroplet leucocyte migration technique for detection of cell-mediated hypersensitivity to PPD and renal carcinoma antigen.
    Sorensen TB; Kjaer M
    Clin Exp Immunol; 1977 Oct; 30(1):168-72. PubMed ID: 606436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypersensitivity to metallic biomaterials: a review of leukocyte migration inhibition assays.
    Hallab N; Jacobs JJ; Black J
    Biomaterials; 2000 Jul; 21(13):1301-14. PubMed ID: 10850924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Activity inhibiting leukocyte migration in human sera of healthy subjects and of subjects with delayed hypersensitivity and findings of possible serum factors with antagonistic activity (author's transl)].
    Jirillo E; De Rinaldis P; Pasquetto N
    Ann Sclavo; 1976; 18(4):623-9. PubMed ID: 1088062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.